Structure and Function of the Human Copper Transporter

人体铜转运蛋白的结构和功能

• 批准号: 7491035
• 负责人: Christopher J Defeo
• 金额: $ 2.53万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-01 至 2008-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7491035
• 关键词: Alzheimer' s Disease; Biochemical; Biochemistry; Carrier Proteins; Cells; Copper; Cryoelectron Microscopy; Cytosol; Data; Destinations; Hand; Helix (Snails); Homeostasis; Human; Ions; Laboratories; Lead; Life; Lipid Bilayers; Membrane; Membrane Proteins; Metals; Molecular Chaperones; Neurodegenerative Disorders; Organism; Outcome Study; Parkinson Disease; Pathway interactions; Personal Satisfaction; Pharmacologic Substance; Physiological; Protein Family; Proteins; Protocols documentation; Research Project Grants; Resolution; Structure; Testing; Transition Elements; Work; design; ear helix; innovation; insight; nervous system disorder; novel therapeutics; particle; prevent; protein structure; reconstruction; research study; three dimensional structure; two-dimensional; uptake

DESCRIPTION (provided by applicant): Copper is essential for life and, not surprisingly, imbalances in copper homeostasis contribute to the progression of many neurodegenerative diseases including Alzheimer's, Creutzfeldt-Jakob and Parkinson's disease. The Copper Uptake transporter (CTR) family of proteins, identified in a variety of eukaryotic organisms, including humans, is required for the cellular uptake of this essential metal ion. Despite its physiological importance, however, it is still unclear how copper is taken up through CTR proteins and how a hazardous accumulation of free copper in the cytosol is prevented. I hypothesize that the human CTR protein (hCTR1) has evolved to accomplish both tasks by first trapping copper after uptake and then handing it off directly to copper chaperone proteins for intracellular distribution. My specific aims are designed to test this hypothesis by solving the 3D structure of hCTR1 (Aim 1) and to determine if and how the transporter and chaperone proteins interact to accomplish copper uptake (Aim 2). The expected results will be milestones in the understanding of copper homeostasis and could help in designing new therapeutics for the treatment of a wide assortment of neurodegenerative diseases.

描述（由申请人提供）：铜是生命所必需的，并且毫不奇怪，铜体内平衡的不平衡有助于许多神经退行性疾病的进展，包括阿尔茨海默病、克雅氏病和帕金森病。在包括人类在内的多种真核生物中鉴定的铜摄取转运蛋白（CTR）家族是细胞摄取这种必需金属离子所必需的。然而，尽管其生理重要性，它仍然是不清楚的铜是如何采取通过CTR蛋白质和如何防止游离铜在胞质溶胶中的危险积累。我假设，人类CTR蛋白（hCTR 1）已经进化到完成这两项任务，首先捕获铜后摄取，然后将其直接交给铜伴侣蛋白的细胞内分布。我的具体目标是通过解决hCTR 1的3D结构来验证这一假设（目标1），并确定转运蛋白和伴侣蛋白是否以及如何相互作用以实现铜的吸收（目标2）。预期的结果将是理解铜稳态的里程碑，并有助于设计用于治疗各种神经退行性疾病的新疗法。